Amanda M Brandow

Summary

Affiliation: Medical College of Wisconsin
Country: USA

Publications

  1. pmc Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use
    Amanda M Brandow
    Section of Pediatric Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Br J Haematol 175:237-245. 2016
  2. pmc Patients with sickle cell disease have increased sensitivity to cold and heat
    Amanda M Brandow
    Section of Pediatric Hematology Oncology, Medical College of Wisconsin, Milwaukee, USA
    Am J Hematol 88:37-43. 2013
  3. pmc Vaso-occlusive painful events in sickle cell disease: impact on child well-being
    Amanda M Brandow
    Department of Pediatric Hematology Oncology, Medical College of Wisconsin, The Children s Research Institute of the Children s Hospital of Wisconsin, Milwaukee, WI 53226, USA
    Pediatr Blood Cancer 54:92-7. 2010
  4. pmc The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations
    Amanda M Brandow
    Section of Pediatric Hematology Oncology, Milwaukee, Wisconsin, USA
    Pediatr Blood Cancer 56:789-93. 2011
  5. pmc Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events
    Amanda M Brandow
    Pediatric Hematology Oncology, Medical College of Wisconsin Children s Research Institute of The Children s Hospital of Wisconsin, Milwaukee, WI 53226, USA
    Br J Haematol 144:782-8. 2009
  6. doi request reprint Dissatisfaction with hospital care for children with sickle cell disease not due only to race and chronic disease
    David C Brousseau
    Department of Pediatrics, Children s Research Institute, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Pediatr Blood Cancer 53:174-8. 2009
  7. pmc Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease
    Cheryl A Hillery
    Department of Pediatrics and Children s Research Institute, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Blood 118:3376-83. 2011
  8. doi request reprint A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease: Visual Analog Scale Versus Numeric Rating Scale
    Matthew P Myrvik
    Medical College of Wisconsin Division of Pediatric Hematology Oncology Transplant Division of Pediatric Emergency Medicine Quantitative Health Sciences, Medical College of Wisconsin, Milwaukee, WI
    J Pediatr Hematol Oncol 37:190-4. 2015
  9. pmc Clinically meaningful measurement of pain in children with sickle cell disease
    Matthew P Myrvik
    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
    Pediatr Blood Cancer 60:1689-95. 2013
  10. pmc The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay
    Amanda M Brandow
    Section of Pediatric Hematology Oncology Section of Quantitative Health Sciences Medical College of Wisconsin Children s Research Institute of the Children s Hospital of Wisconsin, Milwaukee, WI
    J Pediatr Hematol Oncol 37:10-5. 2015

Collaborators

Detail Information

Publications16

  1. pmc Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use
    Amanda M Brandow
    Section of Pediatric Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Br J Haematol 175:237-245. 2016
    ..Patients taking hydroxycarbamide had increased SP (β = 29·2, P = 0·007). SP could be a mediator of or marker for pain sensitization in SCD and a biomarker and/or target for novel pain treatment...
  2. pmc Patients with sickle cell disease have increased sensitivity to cold and heat
    Amanda M Brandow
    Section of Pediatric Hematology Oncology, Medical College of Wisconsin, Milwaukee, USA
    Am J Hematol 88:37-43. 2013
    ..No association with pain, gender, or hemolysis was found. Patients with SCD exhibit hypersensitivity to thermal stimuli suggesting peripheral or central sensitization may exist and could contribute to SCD pain...
  3. pmc Vaso-occlusive painful events in sickle cell disease: impact on child well-being
    Amanda M Brandow
    Department of Pediatric Hematology Oncology, Medical College of Wisconsin, The Children s Research Institute of the Children s Hospital of Wisconsin, Milwaukee, WI 53226, USA
    Pediatr Blood Cancer 54:92-7. 2010
    ..0 Acute Version Generic Core Scales is responsive to change in the evolution of a painful event...
  4. pmc The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations
    Amanda M Brandow
    Section of Pediatric Hematology Oncology, Milwaukee, Wisconsin, USA
    Pediatr Blood Cancer 56:789-93. 2011
    ..Given that little is known about children with SCD and chronic pain, we (1) described characteristics of these children and (2) evaluated the impact of a multidisciplinary pain management model on health care utilization...
  5. pmc Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events
    Amanda M Brandow
    Pediatric Hematology Oncology, Medical College of Wisconsin Children s Research Institute of The Children s Hospital of Wisconsin, Milwaukee, WI 53226, USA
    Br J Haematol 144:782-8. 2009
    ..79; 95% CI = 1.026, 3.096). In conclusion, acute vaso-occlusive painful events impact the lives of children with SCD and their caregivers, even after discharge to home...
  6. doi request reprint Dissatisfaction with hospital care for children with sickle cell disease not due only to race and chronic disease
    David C Brousseau
    Department of Pediatrics, Children s Research Institute, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Pediatr Blood Cancer 53:174-8. 2009
    ..A previous study reported increased dissatisfaction with hospital care for children with sickle cell disease (SCD); however, its small size excluded determining whether race and chronic disease explained the difference...
  7. pmc Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease
    Cheryl A Hillery
    Department of Pediatrics and Children s Research Institute, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Blood 118:3376-83. 2011
    ..Therefore, TRPV1-targeted compounds that lack thermoregulatory side effects may provide relief from pain in patients with SCD...
  8. doi request reprint A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease: Visual Analog Scale Versus Numeric Rating Scale
    Matthew P Myrvik
    Medical College of Wisconsin Division of Pediatric Hematology Oncology Transplant Division of Pediatric Emergency Medicine Quantitative Health Sciences, Medical College of Wisconsin, Milwaukee, WI
    J Pediatr Hematol Oncol 37:190-4. 2015
    ..The agreement between the 2 measures improved at increasing levels of pain severity. These findings demonstrate that the VAS and NRS are similar, but cannot be used interchangeably when assessing self-reported pain in SCD...
  9. pmc Clinically meaningful measurement of pain in children with sickle cell disease
    Matthew P Myrvik
    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
    Pediatr Blood Cancer 60:1689-95. 2013
    ..The current study assessed the minimal clinically significant improvement in pain and pain scores signifying patient-reported need for medication and treatment satisfaction in patients with sickle cell disease (SCD)...
  10. pmc The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay
    Amanda M Brandow
    Section of Pediatric Hematology Oncology Section of Quantitative Health Sciences Medical College of Wisconsin Children s Research Institute of the Children s Hospital of Wisconsin, Milwaukee, WI
    J Pediatr Hematol Oncol 37:10-5. 2015
    ..5; P=0.001). Neuropathic drug use was associated with longer length of stay (risk ratio, 8.3; P<0.0001). Neuropathic drug use in children with SCD was associated with older age, female sex, and longer length of stay...
  11. doi request reprint Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease
    Amanda M Brandow
    Pediatric Hematology Oncology, Medical College of Wisconsin and Children s Research Institute of the Children s Hospital of Wisconsin, Milwaukee, Wiconsin
    Am J Hematol 91:1175-1180. 2016
    ..Prospective trials evaluating the impact of ED care on outcomes of pain hospitalizations could improve SCD pain treatment. Am. J. Hematol. 91:1175-1180, 2016. © 2016 Wiley Periodicals, Inc...
  12. pmc Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature
    Amanda M Brandow
    Section of Pediatric Hematology Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin
    Pediatr Blood Cancer 62:1501-11. 2015
    ..Continued basic and clinical investigation into pain neurobiology is imperative to translate these discoveries into novel ways to assess and treat neuropathic pain and decrease patient suffering...
  13. pmc Neuropathic pain in patients with sickle cell disease
    Amanda M Brandow
    Section of Pediatric Hematology Oncology, Milwaukee, Wisconsin Medical College of Wisconsin, Milwaukee, Wisconsin Children s Research Institute of the Children s Hospital of Wisconsin, Milwaukee, Wisconsin
    Pediatr Blood Cancer 61:512-7. 2014
    ..Neuropathic pain is defined as pain primarily initiated by dysfunction of the peripheral or central nervous system...
  14. doi request reprint Academic attainment findings in children with sickle cell disease
    Amanda S Epping
    Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
    J Sch Health 83:548-53. 2013
    ..This study compared the academic attainment of children with SCD relative to national, state, and local school district rates for African American students...
  15. ncbi request reprint Parental perception of quality of hospital care for children with sickle cell disease
    Jared Kam
    Medical College of Wisconsin, Milwaukee, WI 53226, USA
    WMJ 107:131-5. 2008
    ..Children with sickle cell disease account for 75,000 hospital days annually in the United States, yet little is known about how parents perceive the quality of hospital care these children receive...
  16. pmc Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients With Sickle Cell Disease
    Amanda M Brandow
    Section of Pediatric Hematology Oncology Department of Pediatrics, Medical College of Wisconsin Children s Research Institute, Children s Hospital of Wisconsin, Milwaukee, WI
    J Pediatr Hematol Oncol 38:288-93. 2016
    ..Determining impaired pain sensitivity thresholds increases clinical utility of QST. QST could be a screening tool to phenotype SCD pain, an outcome for pain interventional trials, or guide pain neurobiology investigations. ..